Administration with tPA after stroke exacerbates inflammatory response through various mechanisms including enhancing leukocyte infiltration (Jin et al., 2019) and activating matrix metalloproteinases (MMPs)(Mao et al., 2017). This evidence concerns the gene PLAT and stroke disorder.